Sign In
Last checked at 
1 Nov 2017 15:12
1 November 2017
ConvaTec Group Plc("ConvaTec" or "the Company")Director/PDMR Shareholding
The Company has been notified of the following transaction by a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").
On 30 and 31 October 2017 Frank Schulkes, the Company's Chief Financial Officer and a PDMR, purchased Shares in the Company as follows;
30 October 2017 - 50,000 Shares at £2.014399 per share.
31 October 2017 - 50,000 Shares at £1.959335 per share.
Mr Schulkes' resulting shareholding is 100,000 Shares.
The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1 | Details of the person discharging managerial responsibilities/person closely associated | |||
a) | Name | Frank Schulkes | ||
2 | Reason for the notification | |||
a) | Position/Status | CFO | ||
b) | Initial notification/Amendment | Initial notification | ||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||
a) | Name | ConvaTec Group Plc | ||
b) | LEI | 213800LS272L4FIDOH92 | ||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 10p each in ConvaTec Group Plc ("Shares") GB00BD3VFW73 | ||
b) | Nature of the transaction | 1. Purchase of Shares on 30 October 2017 2. Purchase of Shares on 31 October 2017 | ||
c) | Price(s) and volume(s) | Price(s) 1 - £2.014399 2 - £1.959335 | Volume(s) 1 - 50,000 2 - 50,000 | |
d) | Aggregated information - Aggregated volume - Price |
100,000 £198,686.70 | ||
e) | Date of the transaction | 1 - 30 October 2017 2 - 31 October 2017 | ||
f) | Place of the transaction | London Stock Exchange, Main Market (XLON) | ||
Enquiries
Media
Bobby Leach, VP Group Corporate Affairs, ConvaTec +44 (0)7770 842 226
Alastair Elwen, Finsbury +44 (0)207 251 3801
Analysts and Investors
John Crosse, VP Investor Relations, ConvaTec +44 (0)7500 141 435
Kirsty Law, Director Investor Relations, ConvaTec +44 (0)7470 909 582
investorrelations@convatec.com
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.
Follow the stocks
